{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:07:35Z","timestamp":1791896855705,"version":"4.3.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1007\/s00431-005-0055-2","type":"journal-article","created":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T20:01:20Z","timestamp":1138219280000},"page":"306-319","source":"Crossref","is-referenced-by-count":122,"title":["Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with Crigler-Najjar disease"],"prefix":"10.1007","volume":"165","author":[{"given":"Kevin A.","family":"Strauss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna L.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik J.","family":"Vreman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik G.","family":"Puffenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Holmes","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"55_CR1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1542\/peds.114.2.506","volume":"114","author":"American Academy of Pediatrics","year":"2004","unstructured":"American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia (2004) Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114:297\u2013316","journal-title":"Pediatrics"},{"key":"55_CR2","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1542\/peds.111.5.1110","volume":"111","author":"CE Ahlfors","year":"2003","unstructured":"Ahlfors CE, Herbsman O (2003) Unbound bilirubin in a term newborn with kernicterus. Pediatrics 111:1110\u20131112","journal-title":"Pediatrics"},{"key":"55_CR3","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1053\/j.semperi.2004.09.002","volume":"28","author":"CE Ahlfors","year":"2004","unstructured":"Ahlfors CE, Wennberg RP (2004) Bilirubin-albumin binding and neonatal jaundice. Semin Perinatol 28:334\u2013339","journal-title":"Semin Perinatol"},{"key":"55_CR4","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1542\/peds.18.4.513","volume":"18","author":"DH Andersen","year":"1956","unstructured":"Andersen DH, Blanc WA, Crozier DN, Silverman WA (1956) A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics 18:614\u2013625","journal-title":"Pediatrics"},{"key":"55_CR5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.clp.2004.11.002","volume":"32","author":"VK Bhutani","year":"2005","unstructured":"Bhutani VK, Donn SM, Johnson LH (2005) Risk management of severe neonatal hyperbilirubinemia to prevent kernicterus. Clin Perinatol 32:125\u2013139","journal-title":"Clin Perinatol"},{"key":"55_CR6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1542\/peds.103.1.6","volume":"103","author":"VK Bhutani","year":"1999","unstructured":"Bhutani VK, Johnson L, Sivieri EM (1999) Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 103:6\u201314","journal-title":"Pediatrics"},{"key":"55_CR7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1600-0773.1978.tb02184.x","volume":"42","author":"R Brodersen","year":"1978","unstructured":"Brodersen R (1978) Determination of the vacant amount of high-affinity bilirubin binding site on serum albumin. Acta Pharmacol Toxicol 42:153\u2013158","journal-title":"Acta Pharmacol Toxicol"},{"key":"55_CR8","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/S0021-9258(17)30230-2","volume":"254","author":"R Brodersen","year":"1979","unstructured":"Brodersen R (1979) Bilirubin. Solubility and interaction with albumin and phospholipid. J Biol Chem 254:2364\u20132369","journal-title":"J Biol Chem"},{"key":"55_CR9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/jps.2600720312","volume":"72","author":"R Brodersen","year":"1983","unstructured":"Brodersen R, Ebbesen F (1983) Bilirubin-displacing effect of ampicillin, indomethacin, chlorpromazine, gentamicin, and parabens in vitro and in newborn infants. J Pharm Sci 72:248\u2013253","journal-title":"J Pharm Sci"},{"key":"55_CR10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/00365517709091491","volume":"37","author":"R Brodersen","year":"1977","unstructured":"Brodersen R, Funding L (1977) Binding of bilirubin and long-chain fatty acids to human serum albumin with general remarks on displacement of firmly bound ligands. Scand J Clin Lab Invest 37:257\u2013266","journal-title":"Scand J Clin Lab Invest"},{"key":"55_CR11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000457308","volume":"6","author":"R Brodersen","year":"1983","unstructured":"Brodersen R, Friis-Hansen B, Stern L (1983) Drug-induced displacement of bilirubin from albumin in the newborn. Dev Pharmacol Ther 6:217\u2013229","journal-title":"Dev Pharmacol Ther"},{"key":"55_CR12","first-page":"1493","volume-title":"Fetal and neonatal physiology","author":"WJ Cashore","year":"1998","unstructured":"Cashore WJ (1998) Bilirubin metabolism and toxicity in the newborn. In: Polin RA, Fox WW (eds) Fetal and neonatal physiology. W.B. Saunders, Philadelphia, pp 1493\u20131498"},{"key":"55_CR13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000457309","volume":"6","author":"WJ Cashore","year":"1983","unstructured":"Cashore WJ, Oh W, Brodersen R (1983) Bilirubin-displacing effect of furosemide and sulfisoxazole. An in vitro and in vivo study in neonatal serum. Dev Pharmacol Ther 6:230\u2013238","journal-title":"Dev Pharmacol Ther"},{"key":"55_CR14","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1053\/gast.1997.v112.pm9178703","volume":"112","author":"N Chalasani","year":"1997","unstructured":"Chalasani N, Chowdhury NR, Chowdhury JR, Boyer TD (1997) Kernicterus in an adult who is heterozygous for Crigler-Najjar syndrome and homozygous for Gilbert-type genetic defect. Gastroenterology 112:2099\u20132103","journal-title":"Gastroenterology"},{"key":"55_CR15","first-page":"3063","volume-title":"The metabolic and molecular bases of inherited disease","author":"JR Chowdhury","year":"2001","unstructured":"Chowdhury JR, Wolkoff AW, Chowdhury NR, Arias IM (2001) Hereditary jaundice and disorders of bilirubin metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3063\u20133101"},{"key":"55_CR16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1542\/peds.101.5.825","volume":"101","author":"DA Christakis","year":"1998","unstructured":"Christakis DA, Rivara FP (1998) Pediatricians\u2019 awareness of and attitudes about four clinical practice guidelines. Pediatrics 101:825\u2013830","journal-title":"Pediatrics"},{"key":"55_CR17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1600-0773.1996.tb00012.x","volume":"79","author":"C Cooper-Peel","year":"1996","unstructured":"Cooper-Peel C, Brodersen R, Robertson A (1996) Does ibuprofen affect bilirubin-albumin binding in newborn infant serum? Pharmacol Toxicol 79:297\u2013299","journal-title":"Pharmacol Toxicol"},{"key":"55_CR18","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(58)91849-X","volume":"1","author":"RJ Cremer","year":"1958","unstructured":"Cremer RJ, Perryman PW, Richards DH (1958) Influence of light on the hyperbilirubinaemia of infants. Lancet 1:1094\u20131097","journal-title":"Lancet"},{"key":"55_CR19","first-page":"169","volume":"10","author":"JF Crigler Jr","year":"1952","unstructured":"Crigler JF Jr, Najjar VA (1952) Congenital familial nonhemolytic jaundice with kernicterus. Pediatrics 10:169\u2013180","journal-title":"Pediatrics"},{"key":"55_CR20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1651-2227.1982.tb09376.x","volume":"71","author":"F Ebbesen","year":"1982","unstructured":"Ebbesen F, Brodersen R (1982) Comparison between two preparations of human serum albumin in treatment of neonatal hyperbilirubinaemia. Acta Paediatr Scand 71:85\u201390","journal-title":"Acta Paediatr Scand"},{"key":"55_CR21","first-page":"1505","volume-title":"Fetal and neonatal physiology","author":"JF Ennever","year":"1998","unstructured":"Ennever JF (1998) Phototherapy for neonatal jaundice. In: Polin RA, Fox WW (eds) Fetal and neonatal physiology. W.B. Saunders, Philadelphia, pp 1505\u20131520"},{"key":"55_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1364\/JOSA.33.000568","volume":"33","author":"D Farnsworth","year":"1943","unstructured":"Farnsworth D (1943) The Farnsworth-Munsell 100 hue dichotomous tests for colour vision. J Opt Soc Amer 33:1\u2013586","journal-title":"J Opt Soc Amer"},{"key":"55_CR23","first-page":"873","volume":"80","author":"S Fink","year":"1987","unstructured":"Fink S, Karp W, Robertson A (1987) Ceftriaxone effect on bilirubin-albumin binding. Pediatrics 80:873\u2013875","journal-title":"Pediatrics"},{"key":"55_CR24","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0022-3476(88)80655-3","volume":"113","author":"S Fink","year":"1988","unstructured":"Fink S, Karp W, Robertson A (1988) Effect of penicillins on bilirubin-albumin binding. J Pediatr 113:566\u2013568","journal-title":"J Pediatr"},{"key":"55_CR25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1542\/peds.101.1.25","volume":"101","author":"LM Gartner","year":"1998","unstructured":"Gartner LM, Herrarias CT, Sebring RH (1998) Practice patterns in neonatal hyperbilirubinemia. Pediatrics 101:25\u201331","journal-title":"Pediatrics"},{"key":"55_CR26","first-page":"66","volume":"116","author":"TW Guentert","year":"1990","unstructured":"Guentert TW, Frey BM, Luedin E, Heinzl S, Brodersen R (1990) Increase of plasma nonesterified fatty acid concentration and decrease of albumin binding affinity after intravenous injection of glycocholate-lecithin mixed micelles. J Lab Clin Med 116:66\u201375","journal-title":"J Lab Clin Med"},{"key":"55_CR27","first-page":"137","volume":"25","author":"B Honore","year":"1984","unstructured":"Honore B, Brodersen R (1984) Albumin binding of anti-inflammatory drugs. Utility of a site-oriented versus a stoichiometric analysis. Mol Pharmacol 25:137\u2013150","journal-title":"Mol Pharmacol"},{"key":"55_CR28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000480978","volume":"12","author":"R Ivarsen","year":"1989","unstructured":"Ivarsen R, Brodersen R (1989) Displacement of bilirubin from adult and newborn serum albumin by a drug and fatty acid. Dev Pharmacol Ther 12:19\u201329","journal-title":"Dev Pharmacol Ther"},{"key":"55_CR29","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3109\/00365528109181027","volume":"16","author":"G Jarnerot","year":"1981","unstructured":"Jarnerot G, Andersen S, Esbjorner E, Sandstrom B, Brodersen R (1981) Albumin reserve for binding of bilirubin in maternal and cord serum under treatment with sulphasalazine. Scand J Gastroenterol 16:1049\u20131055","journal-title":"Scand J Gastroenterol"},{"key":"55_CR30","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1067\/mpd.2002.123098","volume":"140","author":"LM Johnson","year":"2002","unstructured":"Johnson LM, Bhutani VK, Brown AK (2002) System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr 140:396\u2013403","journal-title":"J Pediatr"},{"key":"55_CR31","first-page":"519","volume-title":"Greenfield\u2019s neuropathology","author":"HC Kinney","year":"2002","unstructured":"Kinney HC, Armstrong DD (2002) Perinatal neuropathology. In: Graham DI, Lantos PL (eds) Greenfield\u2019s neuropathology. Arnold, London, p 519\u2013606"},{"key":"55_CR32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1651-2227.1972.tb15969.x","volume":"61","author":"N Krukow","year":"1972","unstructured":"Krukow N, Brodersen R (1972) Toxic effects in the Gunn rat of combined treatment with bilirubin and orotic acid. Acta Paediatr Scand 61:697\u2013703","journal-title":"Acta Paediatr Scand"},{"key":"55_CR33","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/archsurg.1996.01430200097017","volume":"131","author":"AA Kuang","year":"1996","unstructured":"Kuang AA, Rosenthal P, Roberts JP, Renz JF, Stock P, Ascher NL, Emond JC (1996) Decreased mortality from technical failure improves results in pediatric liver transplantation. Arch Surg 131:887\u2013892; discussion 892\u2013883","journal-title":"Arch Surg"},{"key":"55_CR34","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1469-8749.1968.tb02927.x","volume":"10","author":"JF Lucey","year":"1968","unstructured":"Lucey JF (1968) The future demise of exchange transfusions for neonatal hyperbilirubinemia. Dev Med Child Neurol 10:521\u2013522","journal-title":"Dev Med Child Neurol"},{"key":"55_CR35","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/BF01955067","volume":"152","author":"E Martin","year":"1993","unstructured":"Martin E, Fanconi S, Kalin P, Zwingelstein C, Crevoisier C, Ruch W, Brodersen R (1993) Ceftriaxone-bilirubin-albumin interactions in the neonate: an in vivo study. Eur J Pediatr 152:530\u2013534","journal-title":"Eur J Pediatr"},{"key":"55_CR36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1542\/peds.91.1.97","volume":"91","author":"SB Meropol","year":"1993","unstructured":"Meropol SB, Luberti AA, De Jong AR, Weiss JC (1993) Home phototherapy: use and attitudes among community pediatricians. Pediatrics 91:97\u2013100","journal-title":"Pediatrics"},{"key":"55_CR37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-8628(19980827)79:1<12::AID-AJMG4>3.0.CO;2-K","volume":"79","author":"H Nazer","year":"1998","unstructured":"Nazer H, Al-Mehaidib A, Shabib S, Ali MA (1998) Crigler-Najjar syndrome in Saudi Arabia. Am J Med Genet 79:12\u201315","journal-title":"Am J Med Genet"},{"key":"55_CR38","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0022-3476(83)80670-2","volume":"102","author":"EM Ostrea","year":"1983","unstructured":"Ostrea EM, Jr., Bassel M, Fleury CA, Bartos A, Jesurun CA (1983) Influence of free fatty acids and glucose infusion on serum bilirubin and bilirubin binding to albumin: clinical implications. J Pediatr 102:426\u2013432","journal-title":"J Pediatr"},{"key":"55_CR39","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0006-8993(01)03186-9","volume":"922","author":"WS Park","year":"2001","unstructured":"Park WS, Chang YS, Chung SH, Seo DW, Hong SH, Lee M (2001) Effect of hypothermia on bilirubin-induced alterations in brain cell membrane function and energy metabolism in newborn piglets. Brain Res 922:276\u2013281","journal-title":"Brain Res"},{"key":"55_CR40","doi-asserted-by":"crossref","first-page":"11689","DOI":"10.1073\/pnas.0401194101","volume":"101","author":"EG Puffenberger","year":"2004","unstructured":"Puffenberger EG, Hu-Lince D, Parod JM, Craig DW, Dobrin SE, Conway AR, Donarum EA, Strauss KA, Dunckley T, Cardenas JF, Melmed KR, Wright CA, Liang W, Stafford P, Flynn CR, Morton DH, Stephan DA (2004) Mapping of sudden infant death with dysgenesis of the testes syndrome (SIDDT) by a SNP genome scan and identification of TSPYL loss of function. Proc Natl Acad Sci USA 101:11689\u201311694","journal-title":"Proc Natl Acad Sci USA"},{"key":"55_CR41","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0889-8553(03)00048-7","volume":"32","author":"EB Rand","year":"2003","unstructured":"Rand EB, Olthoff KM (2003) Overview of pediatric liver transplantation. Gastroenterol Clin North Am 32:913\u2013929","journal-title":"Gastroenterol Clin North Am"},{"key":"55_CR42","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/j.1552-4604.1978.tb01575.x","volume":"18","author":"LF Rasmussen","year":"1978","unstructured":"Rasmussen LF, Ahlfors CE, Wennberg RP (1978) Displacement of bilirubin from albumin by indomethacin. J Clin Pharmacol 18:477\u2013481","journal-title":"J Clin Pharmacol"},{"key":"55_CR43","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0022-3476(76)80557-4","volume":"89","author":"LF Rasmussen","year":"1976","unstructured":"Rasmussen LF, Ahlfors CE, Wennberg RP (1976) The effect of paraben preservatives on albumin binding of bilirubin. J Pediatr 89:475\u2013478","journal-title":"J Pediatr"},{"key":"55_CR44","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0022-3476(83)80671-4","volume":"102","author":"A Robertson","year":"1983","unstructured":"Robertson A, Brodersen R (1983) Effect of lactate, pyruvate, acetone, acetoacetate, and beta-hydroxybutyrate on albumin binding of bilirubin. J Pediatr 102:433\u2013438","journal-title":"J Pediatr"},{"key":"55_CR45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000457504","volume":"17","author":"A Robertson","year":"1991","unstructured":"Robertson A, Brodersen R (1991) Effect of drug combinations on bilirubin-albumin binding. Dev Pharmacol Ther 17:95\u201399","journal-title":"Dev Pharmacol Ther"},{"key":"55_CR46","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-3476(88)80072-6","volume":"112","author":"A Robertson","year":"1988","unstructured":"Robertson A, Fink S, Karp W (1988) Effect of cephalosporins on bilirubin-albumin binding. J Pediatr 112:291\u2013294","journal-title":"J Pediatr"},{"key":"55_CR47","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1651-2227.1991.tb11798.x","volume":"80","author":"A Robertson","year":"1991","unstructured":"Robertson A, Karp W, Brodersen R (1991) Bilirubin displacing effect of drugs used in neonatology. Acta Paediatr Scand 80:1119\u20131127","journal-title":"Acta Paediatr Scand"},{"key":"55_CR48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.siny.2004.09.006","volume":"10","author":"AF Robertson","year":"2005","unstructured":"Robertson AF, Baker JP (2005) Lessons from the past. Semin Fetal Neonatal Med 10:23\u201330","journal-title":"Semin Fetal Neonatal Med"},{"key":"55_CR49","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1542\/peds.79.4.553","volume":"79","author":"PJ Robinson","year":"1987","unstructured":"Robinson PJ, Rapoport SI (1987) Binding effect of albumin on uptake of bilirubin by brain. Pediatrics 79:553\u2013558","journal-title":"Pediatrics"},{"key":"55_CR50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0378-3782(95)01668-6","volume":"43","author":"C Roger","year":"1995","unstructured":"Roger C, Koziel V, Vert P, Nehlig A (1995) Mapping of the consequences of bilirubin exposure in the immature rat: local cerebral metabolic rates for glucose during moderate and severe hyperbilirubinemia. Early Hum Dev 43:133\u2013144","journal-title":"Early Hum Dev"},{"key":"55_CR51","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0022-3468(03)00273-2","volume":"38","author":"R Schauer","year":"2003","unstructured":"Schauer R, Stangl M, Lang T, Zimmermann A, Chouker A, Gerbes AL, Schildberg FW, Rau HG (2003) Treatment of Crigler-Najjar type 1 disease: relevance of early liver transplantation. J Pediatr Surg 38:1227\u20131231","journal-title":"J Pediatr Surg"},{"key":"55_CR52","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/088307389801300605","volume":"13","author":"MI Shevell","year":"1998","unstructured":"Shevell MI, Majnemer A, Schiff D (1998) Neurologic perspectives of Crigler-Najjar syndrome type I. J Child Neurol 13:265\u2013269","journal-title":"J Child Neurol"},{"key":"55_CR53","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1542\/peds.100.5.e9","volume":"100","author":"G Suresh","year":"1997","unstructured":"Suresh G, Lucey JF (1997) Lack of deafness in Crigler-Najjar syndrome type 1: a patient survey. Pediatrics 100:E9","journal-title":"Pediatrics"},{"key":"55_CR54","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.510240205","volume":"24","author":"CN Veere van der","year":"1996","unstructured":"van der Veere CN, Sinaasappel M, McDonagh AF, Rosenthal P, Labrune P, Odievre M, Fevery J, Otte JB, McClean P, Burk G, Masakowski V, Sperl W, Mowat AP, Vergani GM, Heller K, Wilson JP, Shepherd R, Jansen PL (1996) Current therapy for Crigler-Najjar syndrome type 1: report of a world registry. Hepatology 24:311\u2013315","journal-title":"Hepatology"},{"key":"55_CR55","first-page":"400A","volume":"53","author":"HJ Vreman","year":"2003","unstructured":"Vreman HJ, Wong RJ, Murdock JR, Stevenson DK (2003) In vitro efficacy of an LED\u2013based phototherapy device (NeoBLUE\u2122) compared to traditional light sources. Pediatr Res 53:400A","journal-title":"Pediatr Res"},{"key":"55_CR56","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1053\/j.semperi.2004.09.003","volume":"28","author":"HJ Vreman","year":"2004","unstructured":"Vreman HJ, Wong RJ, Stevenson DK (2004) Phototherapy: current methods and future directions. Semin Perinatol 28:326\u2013333","journal-title":"Semin Perinatol"},{"key":"55_CR57","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1128\/AAC.32.10.1571","volume":"32","author":"SJ Wadsworth","year":"1988","unstructured":"Wadsworth SJ, Suh B (1988) In vitro displacement of bilirubin by antibiotics and 2-hydroxybenzoylglycine in newborns. Antimicrob Agents Chemother 32:1571\u20131575","journal-title":"Antimicrob Agents Chemother"},{"key":"55_CR58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2165\/00003088-198713010-00002","volume":"13","author":"PC Walker","year":"1987","unstructured":"Walker PC (1987) Neonatal bilirubin toxicity. A review of kernicterus and the implications of drug-induced bilirubin displacement. Clin Pharmacokinet 13:26\u201350","journal-title":"Clin Pharmacokinet"},{"key":"55_CR59","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1006900111744","volume":"20","author":"RP Wennberg","year":"2000","unstructured":"Wennberg RP (2000) The blood-brain barrier and bilirubin encephalopathy. Cell Mol Neurobiol 20:97\u2013109","journal-title":"Cell Mol Neurobiol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-005-0055-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-005-0055-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-005-0055-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T09:33:41Z","timestamp":1683365621000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-005-0055-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,25]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["55"],"URL":"https:\/\/doi.org\/10.1007\/s00431-005-0055-2","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,25]]}}}